Stock events for USANA Health Sciences, Inc. (USNA)
Over the past six months, USANA Health Sciences, Inc. stock has trended downwards. Shares initially slid following Q3 2025 preliminary earnings due to weaker sales productivity and lower customer acquisition at Hiya. USANA acquired a controlling stake in Hiya Health Products. The company reported mixed Q4 2025 financial results, with revenue slightly missing estimates but adjusted diluted EPS outperforming estimates. Kevin Guest resumed his role as CEO and Executive Chairman, outlining strategic priorities and projecting net sales growth for fiscal year 2026. USANA reported a non-cash impairment charge for Q4 2025.
Demand Seasonality affecting USANA Health Sciences, Inc.’s stock price
USANA Health Sciences' products experience some demand seasonality. The third quarter typically sees strong seasonal demand, often driven by a "back-to-school push" and increased shopping activity. The company anticipates increased investment in customer acquisition for its Hiya business in Q3, aligning with these normal seasonal patterns.
Overview of USANA Health Sciences, Inc.’s business
USANA Health Sciences, Inc. is a global direct-selling company focused on developing, manufacturing, and selling science-based nutritional, personal care, and skincare products. It operates in the Consumer Staples sector, specifically in the Personal Care Products industry, and also falls under Medical - Drugs and Medicinal Chemicals & Botanical Products. USANA's product lines include nutritional optimizers, food products, the Celavive skincare regimen, and Hiya Health Products, a direct-to-consumer children's wellness subsidiary.
USNA’s Geographic footprint
USANA Health Sciences, Inc. distributes its products internationally across the Asia Pacific, the Americas, and Europe. The Asia Pacific region is the company's financial backbone, generating 79.9% of net sales in 2024, with Greater China contributing approximately half of the company's total sales. The Americas and Europe accounted for 20.1% of net sales in 2024.
USNA Corporate Image Assessment
USANA Health Sciences maintains a strong brand reputation, emphasizing its commitment to quality and science-based product development. USANA was named Manufacturer of the Year for the third consecutive year by the Utah Manufacturers Association. The company is trusted by numerous Olympic and professional athletes.
Ownership
USANA Health Sciences, Inc. has a concentrated ownership structure, with insiders holding a significant stake. Dr. Myron W. Wentz, the founder, is the largest individual shareholder. Institutional investors collectively hold a substantial portion of the company's shares.
